Mestinon Lp (Pyridostigmine Bromide)

Pyridostigmine bromide reversibly inhibits the enzyme acetylcholinesterase, which normally breaks down acetylcholine at neuromuscular junctions. By slowing this breakdown, more acetylcholine remains available to bind nicotinic receptors, enhancing nerve‑to‑muscle signaling and improving muscle contraction.

The exact dose of Mestinon Lp is individualized by the prescribing clinician based on the patient’s condition, severity, and response to therapy. Dosage adjustments are typically made gradually to achieve optimal symptom control while minimizing side effects.

Safety data for pyridostigmine bromide in pregnancy and lactation are limited, and the product is classified as having an unknown pregnancy category. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider.

To request Mestinon Lp, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

The primary alternative to pyridostigmine bromide is neostigmine, another reversible acetylcholinesterase inhibitor. Pyridostigmine has a longer duration of action and is generally better tolerated for chronic outpatient use, whereas neostigmine is often reserved for short‑term or intra‑operative situations due to its shorter half‑life and more frequent dosing requirements.

Mestinon Lp should be stored at room temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and avoid storing it in humid or excessively hot environments.

Mestinon Lp is taken orally, usually with a glass of water. It can be taken with or without food, but some patients find that taking it with meals reduces gastrointestinal upset. The tablet should be swallowed whole and not crushed or chewed unless specifically instructed by a healthcare professional.

Serious adverse reactions include marked bradycardia, severe bronchospasm, allergic responses such as rash or anaphylaxis, and worsening of myasthenic symptoms that may affect breathing. Patients should seek immediate medical attention if they experience chest pain, difficulty breathing, sudden weakness, or signs of an allergic reaction.

Mestinon Lp is contraindicated in individuals with known hypersensitivity to pyridostigmine or any tablet excipients, in patients with mechanical intestinal or urinary obstruction, and in those with severe asthma or uncontrolled cardiac arrhythmias. Clinicians should also exercise caution in patients with renal impairment or a history of cholinergic crisis.